Allspring Global Investments Holdings LLC Makes New $1.46 Million Investment in Teladoc Health, Inc. $TDOC

Allspring Global Investments Holdings LLC purchased a new position in shares of Teladoc Health, Inc. (NYSE:TDOC) in the first quarter, HoldingsChannel reports. The institutional investor purchased 276,669 shares of the health services provider’s stock, valued at approximately $1,461,000.

Several other large investors have also recently added to or reduced their stakes in TDOC. Creative Planning lifted its position in shares of Teladoc Health by 7.7% during the third quarter. Creative Planning now owns 20,567 shares of the health services provider’s stock worth $159,000 after purchasing an additional 1,462 shares in the last quarter. Syon Capital LLC lifted its holdings in Teladoc Health by 19.1% in the 4th quarter. Syon Capital LLC now owns 14,140 shares of the health services provider’s stock worth $99,000 after buying an additional 2,264 shares in the last quarter. ProShare Advisors LLC boosted its position in Teladoc Health by 8.2% in the 4th quarter. ProShare Advisors LLC now owns 32,532 shares of the health services provider’s stock valued at $228,000 after buying an additional 2,457 shares during the last quarter. PNC Financial Services Group Inc. boosted its position in Teladoc Health by 177.7% in the 4th quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock valued at $31,000 after buying an additional 2,810 shares during the last quarter. Finally, HighTower Advisors LLC grew its stake in shares of Teladoc Health by 19.2% during the fourth quarter. HighTower Advisors LLC now owns 18,647 shares of the health services provider’s stock valued at $131,000 after acquiring an additional 2,997 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Trading Down 0.5%

NYSE TDOC opened at $8.72 on Monday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 2.72 and a current ratio of 2.80. Teladoc Health, Inc. has a one year low of $4.40 and a one year high of $9.89. The company has a 50-day simple moving average of $8.05 and a 200-day simple moving average of $6.52. The firm has a market capitalization of $1.57 billion, a PE ratio of -8.99 and a beta of 2.10.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share for the quarter, missing the consensus estimate of ($0.35) by ($0.01). Teladoc Health had a negative return on equity of 11.45% and a negative net margin of 6.81%.The business had revenue of $613.85 million for the quarter, compared to analyst estimates of $611.04 million. During the same quarter last year, the company earned ($0.53) EPS. Teladoc Health’s revenue was down 2.5% compared to the same quarter last year. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. On average, equities analysts forecast that Teladoc Health, Inc. will post -0.92 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Adam C. Vandervoort sold 7,906 shares of the stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total value of $60,322.78. Following the sale, the insider owned 110,261 shares of the company’s stock, valued at $841,291.43. This trade represents a 6.69% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Carlos Nueno sold 6,196 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total transaction of $47,275.48. Following the completion of the transaction, the insider owned 57,671 shares of the company’s stock, valued at approximately $440,029.73. This trade represents a 9.70% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 39,195 shares of company stock valued at $299,058 in the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have weighed in on TDOC. Bank of America raised their price objective on Teladoc Health from $9.00 to $10.50 and gave the company a “buy” rating in a research note on Tuesday, July 7th. Canaccord Genuity Group upped their target price on Teladoc Health from $10.00 to $11.00 and gave the company a “buy” rating in a research report on Tuesday, July 21st. Weiss Ratings upgraded Teladoc Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, May 22nd. Finally, Citigroup raised their price target on shares of Teladoc Health from $6.00 to $7.00 and gave the stock a “neutral” rating in a research report on Tuesday, May 5th. Five investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $7.57.

Teladoc Health Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.